| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.4M | +8.8% |
| R&D Expense | $39.8M | +23.7% |
| SG&A Expense | $27.6M | +3.3% |
| Operating Income | -$62.9M | -14.9% |
| Pre-tax Income | -$67.8M | -25.5% |
| Income Tax | $0 | — |
| Net Income | -$67.8M | -25.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $24.3M | -60.5% |
| Total Assets | $43.5M | -47.2% |
| Current Liabilities | $23.0M | +6.7% |
| Long-term Debt | $27.5M | +0.7% |
| Total Liabilities | $55.7M | +5.4% |
| Stockholders' Equity | -$12.2M | -141.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.0M | -35.2% |
| Capital Expenditures | $185K | -94.5% |
| Investing Cash Flow | -$311K | +90.8% |
| Financing Cash Flow | $17.3M | -73.3% |
| Free Cash Flow | -$57.1M | -25.5% |